Bildgebende Diagnostik des hepatozellulären Karzinoms Untersuchungstechnik, Ergebnisse und Indikationsstellung

[1]  M. Arguedas.  Screening for hepatocellular carcinoma: Why, when, how? , 2003, Current gastroenterology reports.

[2]  M. Kudo,et al.  Contrast-enhanced subtraction harmonic sonography for evaluating treatment response in patients with hepatocellular carcinoma. , 2001, AJR. American journal of roentgenology.

[3]  T. Murakami,et al.  Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. , 2001, Radiology.

[4]  H. Sekihara,et al.  Contrast‐enhanced, wide‐band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[5]  M. Makuuchi,et al.  New lesions detected by intraoperative ultrasound during liver resection for hepatocellular carcinoma. , 2001, Ultrasound in medicine & biology.

[6]  R. Baron,et al.  Radiologic diagnosis of hepatocellular carcinoma. , 2001, Clinics in liver disease.

[7]  J. Lim,et al.  Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. , 2001, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[8]  B. McMahon,et al.  Screening for hepatocellular carcinoma in Alaska natives infected with chronic hepatitis B: A 16‐year population‐based study , 2000, Hepatology.

[9]  J. Furuse,et al.  Assessment of arterial tumor vascularity in small hepatocellular carcinoma. Comparison between color doppler ultrasonography and radiographic imagings with contrast medium: dynamic CT, angiography, and CT hepatic arteriography. , 2000, European journal of radiology.

[10]  W. Pegios,et al.  Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials. , 2000, Radiology.

[11]  G. Marchal,et al.  Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study. , 2000, Radiology.

[12]  K. Ohtomo,et al.  Evaluation of gadobenate dimeglumine in hepatocellular carcinoma: Results from phase II and phase III clinical trials in Japan , 1999, Journal of magnetic resonance imaging : JMRI.

[13]  Y. Yamashita,et al.  Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging. , 1999, AJR. American journal of roentgenology.

[14]  P. R. Ros,et al.  Fibrolamellar carcinoma of the liver: radiologic-pathologic correlation. , 1999, Radiographics : a review publication of the Radiological Society of North America, Inc.

[15]  H. Fagertun,et al.  Sequence optimization in mangafodipir trisodium‐enhanced liver and pancreas MRI , 1999, Journal of magnetic resonance imaging : JMRI.

[16]  A. Spinazzi,et al.  Gadobenate dimeglumine (Gd-BOPTA). An overview. , 1998, Investigative radiology.

[17]  T. Ichikawa,et al.  Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. , 1998, AJR. American journal of roentgenology.

[18]  W. Pegios,et al.  Hepatocellular carcinoma: evaluation with dynamic and static gadobenate dimeglumine-enhanced MR imaging and histopathologic correlation. , 1997, Radiology.

[19]  P. Neuhaus,et al.  Dynamische und statische MRT mit dem superparamagnetischen MRT-Kontrastmittel Resovist® zur Darstellung von primären und sekundären Lebertumoren , 1997 .

[20]  P. Robinson,et al.  Hepatic lesion detection at MR imaging: a comparative study with four sequences. , 1997, Radiology.

[21]  M. Mack,et al.  Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient. , 1996, Investigative radiology.

[22]  M. Mack,et al.  Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA. , 1996, Radiology.

[23]  G. Morana,et al.  Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)--preliminary results of phase II clinical application. , 1996, Radiology.

[24]  W. Pegios,et al.  Superparamagnetic iron oxide--enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions. , 1996, Radiology.

[25]  A. Rahmouni,et al.  Calcification in focal nodular hyperplasia: a new problem for differentiation from fibrolamellar hepatocellular carcinoma. , 1996, Radiology.

[26]  T. Murakami,et al.  Detection of Hypervascular Hepatocellular Carcinoma by Dynamic MRI and Dynamic Spiral CT , 1995, Journal of computer assisted tomography.

[27]  D. Khayat,et al.  Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging. , 1994, Radiology.

[28]  J. Spaeth,et al.  Detection of hypervascular brown tumors on three-phase bone scan. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  C. McMahon,et al.  Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers. , 1992, AJR. American journal of roentgenology.

[30]  M. Bernardino,et al.  Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity. , 1992, Radiology.

[31]  R. Brasch.  New directions in the development of MR imaging contrast media. , 1992, Radiology.

[32]  R. Romagnoli,et al.  MRI of small hepatocellular carcinoma: comparison with US, CT, DSA, and Lipiodol-CT. , 1992, Journal of computer assisted tomography.

[33]  T. Desser,et al.  A multicenter, randomized, double-blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: results of a Phase III clinical trial. , 1999, Journal of magnetic resonance imaging : JMRI.

[34]  K. Hergan,et al.  [Contrast-enhanced subtraction MRT in the spin-echo technic]. , 1998, RöFo. Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren (Print).

[35]  C. McMahon,et al.  Mn‐DPDP enhancement patterns of hepatocellular lesions on MR images , 1993, Journal of magnetic resonance imaging : JMRI.

[36]  T. Vogl,et al.  Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients. , 1992, Radiology.

[37]  R Weissleder,et al.  Primary liver tumors: diagnosis by MR imaging. , 1989, AJR. American journal of roentgenology.